Hepatic failure and enhanced oxidative stress in mitochondrial diabetes

Endocrine Journal

Volumn 55, Issue 3, 2008, Pages 509-514

  Takahashi, Yutaka ^a   IIda, Keiji ^a   Takeno, Ryoko ^a   Kitazawa, Riko ^a   Kitazawa, Sohei ^a   Kitamura, Hidetsuna ^a   Fujioka, Yoshio ^a   Yamada, Hiroyuki ^a   Kanda, Fumio ^a   Ohta, Shigeo ^b   Nishimaki, Kiyomi ^b   Fujimoto, Masayo ^a   Kondo, Takeshi ^a   Iguchi, Genzo ^a   Takahashi, Kentaro ^a   Kaji, Hidesuke ^c   Okimura, Yasuhiko ^d   Chihara, Kazuo ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Graduate School of Medicine   (Japan)

^c Department of Physiology and Biochemistry   (Japan)

^d KOBE UNIVERSITY   (Japan)

Author keywords

Diabetes; Hepatic steatosis; Mitochondria; Mutation; Oxidative stress

Indexed keywords

REACTIVE OXYGEN METABOLITE;

ADULT; ARTICLE; CASE REPORT; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ELECTRON MICROSCOPY; FATTY LIVER; HEART MUSCLE CELL; HETEROPLASMY; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; IMMUNOHISTOCHEMISTRY; LIVER; LIVER FAILURE; MALE; MATERNALLY INHERITED DIABETES AND DEAFNESS; MITOCHONDRION; MUSCLE CELL; MUTATION; OXIDATIVE STRESS; PATHOGENESIS; SKELETAL MUSCLE; ULTRASTRUCTURE;

AUTOPSY; DIABETES COMPLICATIONS; DIABETES MELLITUS; FATAL OUTCOME; GENES, MITOCHONDRIAL; HUMANS; LIVER FAILURE; MALE; MIDDLE AGED; MUTATION; OXIDATIVE STRESS; RNA, TRANSFER, LEU;

EID: 46749153447     PISSN: 09188959     EISSN: 13484540     Source Type: Journal    
DOI: 10.1507/endocrj.K07E-091     Document Type: Article

References (12)

1. Reardon W, Ross RJ, Sweeney MG, Luxon LM, Pembrey ME, Harding AE, Trembath RC (1992) Diabetes mellitus associated with a pathogenic point mutation in mitochondrial DNA. Lancet 340: 1376-1379.
2. Maassen JA, LM TH, Van Essen E, Heine RJ, Nijpels G, Jahangir Tafrechi RS, Raap AK, Janssen GM, Lemkes HH (2004) Mitochondrial diabetes: molecular mechanisms and clinical presentation. Diabetes 53 Suppl 1, S103-109.
3. McFarland R, Taylor RW, Turnbull DM (2002) The neurology of mitochondrial DNA disease. Lancet Neurol 1: 343-351.
4. Fischel-Ghodsian N (2003) Mitochondrial deafness. Ear Hear 24: 303-313.
5. Finsterer J (2006) Overview on visceral manifestations of mitochondrial disorders. Neth J Med 64: 61-71.
6. Finsterer J (2004) Mitochondriopathies. Eur J Neurol 11: 163-186.
7. Nomiyama T, Tanaka Y, Hattori N, Nishimaki K, Nagasaka K, Kawamori R, Ohta S (2002) Accumulation of somatic mutation in mitochondrial DNA extracted from peripheral blood cells in diabetic patients. Diabetologia 45: 1577-1583.
8. Kadowaki T, Kadowaki H, Mori Y, Tobe K, Sakuta R, Suzuki Y, Tanabe Y, Sakura H, Awata T, Goto Y, et al. (1994) A subtype of diabetes mellitus associated with a mutation of mitochondrial DNA. N Engl J Med 330: 962-968.
9. Toyokuni S, Tanaka T, Hattori Y, Nishiyama Y, Yoshida A, Uchida K, Hiai H, Ochi H, Osawa T (1997) Quantitative immunohistochemical determination of 8-hydroxy-2′-deoxyguanosine by a monoclonal antibody N45.1: its application to ferric nitrilotriacetate-induced renal carcinogenesis model. Lab Invest 76: 365-374.
10. Kitazawa R, Kitazawa S, Yoon S, Kasuga M, Maeda S (1999) In situ demonstration of parathyroid hormone-related protein mRNA in sclerosing hepatic carcinoma. Virchows Arch 435: 137-142.
11. Chinnery PF, DiMauro S (2005) Mitochondrial hepato-pathies. J Hepatol 43: 207-209.
12. Korenaga M, Okuda M, Otani K, Wang T, Li Y, Weinman SA (2005) Mitochondrial dysfunction in hepatitis C. J Clin Gastroenterol 39: S162-166.